Annual EPS
-$0.30
-$0.10-50.00%
31 December 2023
Summary:
XTL Biopharmaceuticals annual earnings per share is currently -$0.30, with the most recent change of -$0.10 (-50.00%) on 31 December 2023. During the last 3 years, it has risen by +$0.30 (+50.00%). XTLB annual EPS is now -106.82% below its all-time high of $4.40, reached on 31 December 2009.XTLB EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
$0.10
+$0.10+100.00%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly earnings per share is currently $0.10, with the most recent change of +$0.10 (+100.00%) on 31 March 2024. Over the past year, it has increased by +$0.16 (+255.04%). XTLB quarterly EPS is now -97.62% below its all-time high of $4.20, reached on 31 December 2009.XTLB Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$0.03
+$0.27+89.57%
31 March 2024
Summary:
XTL Biopharmaceuticals TTM earnings per share is currently -$0.03, with the most recent change of +$0.27 (+89.57%) on 31 March 2024. Over the past year, it has increased by +$0.37 (+92.18%). XTLB TTM EPS is now -100.34% below its all-time high of $9.12, reached on 31 December 2009.XTLB TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -50.0% | +255.0% | +92.2% |
| 3 y3 years | +50.0% | +200.0% | +92.2% |
| 5 y5 years | -142.9% | +140.6% | -112.3% |
XTLB EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -719.7% | +50.0% | -62.0% | +159.3% | -120.0% | +93.8% |
| 5 y | 5 years | -142.9% | +50.0% | -62.0% | +140.6% | -112.3% | +96.6% |
| alltime | all time | -106.8% | +99.6% | -97.6% | +100.2% | -100.3% | +100.0% |
XTL Biopharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $0.10(>+9900.0%) | -$0.03(-89.6%) |
| Dec 2023 | -$0.30(+50.0%) | $0.00(-100.0%) | -$0.30(-25.0%) |
| Sept 2023 | - | -$0.06(-3.4%) | -$0.40(-16.0%) |
| June 2023 | - | -$0.07(-60.4%) | -$0.48(-6.5%) |
| Mar 2023 | - | -$0.17(+68.7%) | -$0.51(+105.6%) |
| Dec 2022 | -$0.20(+446.4%) | -$0.10(-28.9%) | -$0.25(-314.1%) |
| Sept 2022 | - | -$0.14(+40.6%) | $0.12(-26.0%) |
| June 2022 | - | -$0.10(-207.6%) | $0.16(+177.6%) |
| Mar 2022 | - | $0.09(-64.7%) | $0.06(-11.2%) |
| Dec 2021 | -$0.04(-93.9%) | $0.26(-363.4%) | $0.06(-115.9%) |
| Sept 2021 | - | -$0.10(-50.0%) | -$0.40(-20.0%) |
| June 2021 | - | -$0.20(-300.0%) | -$0.50(0.0%) |
| Mar 2021 | - | $0.10(-150.0%) | -$0.50(-11.7%) |
| Dec 2020 | -$0.60(+500.0%) | -$0.20(0.0%) | -$0.57(+20.8%) |
| Sept 2020 | - | -$0.20(0.0%) | -$0.47(-9.0%) |
| June 2020 | - | -$0.20(-695.2%) | -$0.51(-43.7%) |
| Mar 2020 | - | $0.03(-132.8%) | -$0.91(+516.4%) |
| Dec 2019 | -$0.10(-114.3%) | -$0.10(-58.4%) | -$0.15(-158.4%) |
| Sept 2019 | - | -$0.25(-59.0%) | $0.25(-63.7%) |
| June 2019 | - | -$0.60(-175.0%) | $0.70(-36.4%) |
| Mar 2019 | - | $0.80(+166.7%) | $1.10(+57.1%) |
| Dec 2018 | $0.70(-450.0%) | $0.30(+50.0%) | $0.70(+75.0%) |
| Sept 2018 | - | $0.20(-200.0%) | $0.40(-33.3%) |
| June 2018 | - | -$0.20(-150.0%) | $0.60(+13.2%) |
| Mar 2018 | - | $0.40(>+9900.0%) | $0.53(-412.0%) |
| Dec 2017 | -$0.20(-77.8%) | $0.00(-100.0%) | -$0.17(-70.2%) |
| Sept 2017 | - | $0.40(-248.2%) | -$0.57(-46.7%) |
| June 2017 | - | -$0.27(-10.0%) | -$1.07(+7.0%) |
| Mar 2017 | - | -$0.30(-25.0%) | -$1.00(+11.1%) |
| Dec 2016 | -$0.90(-47.1%) | -$0.40(+300.0%) | -$0.90(-35.7%) |
| Sept 2016 | - | -$0.10(-50.0%) | -$1.40(-6.7%) |
| June 2016 | - | -$0.20(0.0%) | -$1.50(+7.1%) |
| Mar 2016 | - | -$0.20(-77.8%) | -$1.40(-17.6%) |
| Dec 2015 | -$1.70(+54.5%) | -$0.90(+350.0%) | -$1.70(+54.5%) |
| Sept 2015 | - | -$0.20(+100.0%) | -$1.10(-8.3%) |
| June 2015 | - | -$0.10(-80.0%) | -$1.20(-7.7%) |
| Mar 2015 | - | -$0.50(+66.7%) | -$1.30(+18.2%) |
| Dec 2014 | -$1.10(0.0%) | -$0.30(0.0%) | -$1.10(-15.4%) |
| Sept 2014 | - | -$0.30(+50.0%) | -$1.30(+62.5%) |
| June 2014 | - | -$0.20(-33.3%) | -$0.80(-20.0%) |
| Mar 2014 | - | -$0.30(-40.0%) | -$1.00(-9.1%) |
| Dec 2013 | -$1.10 | -$0.50(-350.0%) | -$1.10(+57.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $0.20(-150.0%) | -$0.70(-24.3%) |
| June 2013 | - | -$0.40(0.0%) | -$0.92(+12.1%) |
| Mar 2013 | - | -$0.40(+300.0%) | -$0.82(+32.0%) |
| Dec 2012 | -$0.60(0.0%) | -$0.10(+308.2%) | -$0.62(-6.2%) |
| Sept 2012 | - | -$0.02(-91.8%) | -$0.67(-17.4%) |
| June 2012 | - | -$0.30(+50.0%) | -$0.81(+25.3%) |
| Mar 2012 | - | -$0.20(+41.6%) | -$0.64(0.0%) |
| Dec 2011 | -$0.60(-45.5%) | -$0.14(-14.5%) | -$0.64(-3.5%) |
| Sept 2011 | - | -$0.17(+20.4%) | -$0.67(-5.0%) |
| June 2011 | - | -$0.14(-31.4%) | -$0.70(-34.1%) |
| Mar 2011 | - | -$0.20(+21.7%) | -$1.06(-27.3%) |
| Dec 2010 | -$1.10(-125.0%) | -$0.16(-17.8%) | -$1.46(-150.5%) |
| Sept 2010 | - | -$0.20(-60.0%) | $2.90(-6.9%) |
| June 2010 | - | -$0.50(-16.7%) | $3.12(-45.5%) |
| Mar 2010 | - | -$0.60(-114.3%) | $5.72(-37.3%) |
| Dec 2009 | $4.40(-114.0%) | $4.20(>+9900.0%) | $9.12(-197.1%) |
| Sept 2009 | - | $0.02(-99.3%) | -$9.38(-18.4%) |
| June 2009 | - | $2.10(-25.0%) | -$11.50(-21.2%) |
| Mar 2009 | - | $2.80(-119.6%) | -$14.60(-21.6%) |
| Dec 2008 | -$31.50(-42.7%) | -$14.30(+581.0%) | -$18.61(+331.4%) |
| Sept 2008 | - | -$2.10(+110.0%) | -$4.32(-72.8%) |
| June 2008 | - | -$1.00(-17.7%) | -$15.86(-51.0%) |
| Mar 2008 | - | -$1.22(<-9900.0%) | -$32.35(-1.6%) |
| Dec 2007 | -$55.00(+37.5%) | $0.00(-100.0%) | -$32.89(-18.9%) |
| Sept 2007 | - | -$13.64(-22.1%) | -$40.58(+6.1%) |
| June 2007 | - | -$17.50(+900.0%) | -$38.24(+24.4%) |
| Mar 2007 | - | -$1.75(-77.2%) | -$30.74(-21.2%) |
| Dec 2006 | -$40.00(0.0%) | -$7.69(-32.0%) | -$38.99(-43.1%) |
| Sept 2006 | - | -$11.30(+13.0%) | -$68.55(+17.2%) |
| June 2006 | - | -$10.00(0.0%) | -$58.50(+20.2%) |
| Mar 2006 | - | -$10.00(-73.2%) | -$48.65(+23.5%) |
| Dec 2005 | -$40.00(-33.3%) | -$37.25(+2880.0%) | -$39.40(-31.7%) |
| Sept 2005 | - | -$1.25(+733.3%) | -$57.65(-0.4%) |
| June 2005 | - | -$0.15(-80.0%) | -$57.90(-3.5%) |
| Mar 2005 | - | -$0.75(-98.6%) | -$60.00(-1.2%) |
| Dec 2004 | -$60.00(-7.7%) | -$55.50(+3600.0%) | -$60.75(+1057.1%) |
| Sept 2004 | - | -$1.50(-33.3%) | -$5.25(+40.0%) |
| June 2004 | - | -$2.25(+50.0%) | -$3.75(+150.0%) |
| Mar 2004 | - | -$1.50 | -$1.50 |
| Dec 2003 | -$65.00(-13.3%) | - | - |
| Dec 2002 | -$75.00(+36.4%) | - | - |
| Dec 2001 | -$55.00 | - | - |
FAQ
- What is XTL Biopharmaceuticals annual earnings per share?
- What is the all time high annual EPS for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual EPS year-on-year change?
- What is XTL Biopharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly EPS year-on-year change?
- What is XTL Biopharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals TTM EPS year-on-year change?
What is XTL Biopharmaceuticals annual earnings per share?
The current annual EPS of XTLB is -$0.30
What is the all time high annual EPS for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual earnings per share is $4.40
What is XTL Biopharmaceuticals annual EPS year-on-year change?
Over the past year, XTLB annual earnings per share has changed by -$0.10 (-50.00%)
What is XTL Biopharmaceuticals quarterly earnings per share?
The current quarterly EPS of XTLB is $0.10
What is the all time high quarterly EPS for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly earnings per share is $4.20
What is XTL Biopharmaceuticals quarterly EPS year-on-year change?
Over the past year, XTLB quarterly earnings per share has changed by +$0.16 (+255.04%)
What is XTL Biopharmaceuticals TTM earnings per share?
The current TTM EPS of XTLB is -$0.03
What is the all time high TTM EPS for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM earnings per share is $9.12
What is XTL Biopharmaceuticals TTM EPS year-on-year change?
Over the past year, XTLB TTM earnings per share has changed by +$0.37 (+92.18%)